✦ LIBER ✦

503 Early prediction of sustained virological response (SVR) during treatment with peginterferon alfa-2A (40KD) (PEGASYS®) plus ribavirin (RBV) (COPEGUS®) in patients with chronic hepatitis C (CHC) and persistently normal alanine aminotransferase (ALT) levels

✍ Scribed by P.J. Pockros; M. Diago; E. Gane; K.R. Reddy; D. Prati; M.L. Shiffman; P. Farci; C. O'Brien; P. Lardelli; F. Lamour; S. Zeuzem

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of patients with chronic hepat

✍ M. Swain; M.-Y. Lai; M.L. Shiffman; W.G. Cooksley; A. Abergel; M. Diago; M. Brun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

507 Early prediction of sustained virolo

✍ M. Rodriguez-Torres; F.J. Torriani; E. Lissen; N. Brau; M. Sulkowski; R. Sola; B 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

475 Sustained virological response (SVR)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB

499 The impact of sustained virological

✍ C. O'Brien; N. Wintfeld; K.K. Patel; S. Zeuzem; M.L. Shiffman; M. Diago; A. Tran 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

522 Combination therapy with peginterfer

✍ O. Weiland; M.W. Fried; S.J. Hadziyannis; G.R. Foster; D. Messinger; K. Freivoge 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 62 KB

612 Prediction of sustained virological

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB